SecBot SecBot
8-K ·Filed Apr 30, 2026

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001213900-26-049748
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor the next quarterly filing for any changes in financial reporting quality or strategy under the new CFO. The orderly transition with an internal successor suggests no disruption, but Volker's dual COO/CFO role may signal cost consolidation or operational focus.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NMTC ▼ -62.55% at T+60d
NEUTRAL call -62.55% · α vs SPY -65.66% · entry $4.70 → $1.76
Entry = T+0 close
Apr 30, 2026
via day close
T+1d
-7.45%
call -7.45% · α -7.67%
$4.35
settled 6mo ago
T+5d
-8.51%
call -8.51% · α -10.24%
$4.30
settled 6mo ago
T+20d
-20.85%
call -20.85% · α -25.82%
$3.72
settled 5mo ago
T+60d
-62.55%
call -62.55% · α -65.66%
$1.76
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

CFO Ronald McClurg is retiring effective June 30, 2026, with COO Christopher Volker succeeding him as CFO on July 1, 2026. McClurg will remain as a Senior Advisor through December 31, 2026, under a transition agreement. This is a planned, orderly succession with an internal replacement, not a sudden departure.

Key Facts

  • CFO Ronald McClurg notified the company of his retirement on April 24, 2026, effective June 30, 2026.
  • COO Christopher Volker will succeed McClurg as CFO effective July 1, 2026.
  • McClurg will stay as a Senior Advisor through December 31, 2026, for transition support.
  • Volker's base salary will increase to $350,000 as CFO; other compensation terms unchanged.
  • McClurg entered into a Transition and Release Agreement dated April 28, 2026, with a general release of claims and non-disparagement covenant.
  • McClurg holds stock options for 76,410 shares and 9,476 unvested RSUs, which continue per their terms post-separation.

Financial Impact

No material financial impact disclosed. Volker's salary increase to $350,000 is a routine compensation adjustment.

Risk Factors

  • Potential distraction during the transition period through year-end 2026.
  • Volker's dual role as COO and CFO could indicate resource constraints at a $40M market cap company.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-049748
Document: ea0288229-8k_neuroone.htm0001213900-26-049748
Document: 0001213900-26-049748-index-headers.html0001213900-26-049748
Document: 0001213900-26-049748-index.html0001213900-26-049748
Document: 0001213900-26-049748.txt0001213900-26-049748
10 reports for NMTC
Performance horizon
67% Hit rate @ T+1 4 of 6 directional calls Went positive at some point 4 of 6 best @ T+60▲ +50.00%Jun 12, 2026
Filters
Rows
Reports for NMTC — sortable, filterable
TypeNow
Oct 5, 2026
22d ago
8-K
BULLISH ★ 6/10
$1.12 $1.13▲ +1.35%▲ +0.80%$0.8040 (−27.89%)
Oct 5, 2026
22d ago
Press Release
MIXED ★ 5/10
$1.12 $1.13▲ +1.35%▲ +0.80%$0.8040 (−27.89%)
Aug 27, 2026
8w ago
8-K
BULLISH ★ 5/10
$1.98 $1.77▼ −10.61%▼ −10.38%$0.8040 (−59.39%)
Aug 13, 2026
10w ago
8-K
MIXED ★ 5/10
$1.83 $1.94▲ +6.01%▲ +6.21%$0.8040 (−56.07%)
Jun 12, 2026
19w ago
424B5 / 8-K
BEARISH ★ 6/10
$3.32 $3.25▲ +2.11%▲ +1.51%$0.8040 (+75.78%)
May 22, 2026
22w ago
8-K
BEARISH ★ 7/10
$3.87 $3.73▲ +3.62%▲ +3.63%$0.8040 (+79.22%)
May 12, 2026
24w ago
8-K
BULLISH ★ 6/10
$4.39 $4.51▲ +2.73%▲ +2.16%$0.8040 (−81.69%)
May 4, 2026
25w ago
8-K
BULLISH ★ 5/10
$4.49 $4.43▼ −1.34%▼ −2.13%$0.8040 (−82.09%)
Apr 30, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$4.70 $4.35▼ −7.45%▼ −7.67%$0.8040 (−82.89%)
Feb 25, 2026
34w ago
8-K
NEUTRAL ★ 3/10
$4.15 $4.02▼ −3.04%▼ −2.59%$0.8040 (−80.61%)
Showing 10 of 10

US Market Status

Market Closed — Opens Thu (12h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026